Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
European Thyroid Journal
|
June 20, 2025
Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus
Aleš Ryška, Jaume Capdevila, Matthias S Dettmer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 6, 2022
Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study
Carlos E Cardenas, Sanne E Blinde, Abdallah S R Mohamed, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
Jan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
Journal for Immunotherapy of Cancer
|
August 8, 2020
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
Eva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, et al.
European Thyroid Journal
|
October 13, 2022
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
Chantal A Lebbink, Thera P Links, Agnieszka Czarniecka, et al.
Radiation Oncology (London, England)
|
May 15, 2015
Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study
Liam Welsh, Rafal Panek, Dualta McQuaid, et al.
European Thyroid Journal
|
June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer
Jan Taprogge, Iain Murray, Hannah Sharman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2010
Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers
Kevin J Harrington, Eleni M Karapanagiotou, Victoria Roulstone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2015
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
Martin Schlumberger, Barbara Jarzab, Maria E Cabanillas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
Lori J Wirth, Marcia S Brose, Eric J Sherman, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
European Thyroid Journal
|
June 20, 2025
Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus
Aleš Ryška, Jaume Capdevila, Matthias S Dettmer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 6, 2022
Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study
Carlos E Cardenas, Sanne E Blinde, Abdallah S R Mohamed, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
Jan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
Journal for Immunotherapy of Cancer
|
August 8, 2020
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
Eva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, et al.
European Thyroid Journal
|
October 13, 2022
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
Chantal A Lebbink, Thera P Links, Agnieszka Czarniecka, et al.
Radiation Oncology (London, England)
|
May 15, 2015
Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study
Liam Welsh, Rafal Panek, Dualta McQuaid, et al.
European Thyroid Journal
|
June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer
Jan Taprogge, Iain Murray, Hannah Sharman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2010
Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers
Kevin J Harrington, Eleni M Karapanagiotou, Victoria Roulstone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2015
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
Martin Schlumberger, Barbara Jarzab, Maria E Cabanillas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
Lori J Wirth, Marcia S Brose, Eric J Sherman, et al.
Page
of 8